article thumbnail

Amid GLP-1 boom, Novo Nordisk strikes up insulin partnership in Indonesia

Fierce Pharma

While much of the attention on Novo Nordisk these days revolves around the company’s wildly popular GLP-1 drugs Ozempic and Wegovy, insulin remains a critical backbone for the drugmaker. |

Insulin 103
article thumbnail

Key senators make a big pivot on bipartisan insulin cost proposal

STAT News

WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate, a pair of key senators have significantly changed a proposal to cap insulin costs. The new legislation by Senate Diabetes Caucus co-chairs Sens. Jeanne Shaheen (D-N.H.) Jeanne Shaheen (D-N.H.) Read the rest…

Insulin 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tjoapack and Biopharma: Our Packaging Options

Pharma Packaging Solutions

Biopharma Packaging from Tjoapack Biopharmaceutical technology is advancing every day as scientists work to create new, better treatments for diseases that millions struggle with on a daily basis. With biologic treatments becoming ever more available, the need for smart, reliable biopharma packaging is on the rise.

article thumbnail

What Are Biopharmaceuticals?

Pharma Packaging Solutions

Hormones (such as insulin, glucagon, and growth hormone, to name a few) are produced by recombinant DNA, as are blood factors, thrombolytic agents, interferons, monoclonal antibodies, therapeutic enzymes, and more. We offer a variety of packaging services, including vial and ampule labeling, pharmaceutical kit assembly, and more.

article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328
article thumbnail

New Stelo TV Commercial Talks About Health Revolution with Glucose Monitoring

XTalks

The new Stelo TV commercial shows people going about their everyday lives, saying how they’re already tracking many things, from the distances they travel to weather forecasts to tracking packages and their sleep. It’s time for an easy way to track your glucose. The global CGM market was valued at approximately $4.60

Insulin 52
article thumbnail

Roche debuts smart glucose monitor for hospital use

pharmaphorum

” The Android-powered device can run certified third-party software, initially shipping with a handful of apps including Glytec’s Glucommander insulin-dosing software under the terms of a deal announced today.

Insulin 128